Literature DB >> 8679708

Characterization of the human and mouse Fli-1 promoter regions.

B Barbeau1, D Bergeron, M Beaulieu, Z Nadjem, E Rassart.   

Abstract

Overexpression of the Fli-1 gene has been shown to be involved in retrovirus-induced mouse tumors. Cloning of the 5' flanking sequence of the mouse and human Fli-1 exon 1 was performed. At least two major transcription initiation sites were localized respectively at 143 and 114 nucleotides upstream of the previously defined mouse Fli-1 cDNA 5' end. The sequences flanking the CAP sites show good conservation between human and mouse (94%). The promoter region contains a potential TATA box lying 30 bp from one of the major identified CAP sites. Several conserved elements, such as GATA, EBS, GC rich, AP-2, AP-3 elements and a repetition of GA were observed next to the two major CAP sites. Furthermore, this latter was shown to form a H-DNA structure in vitro by S1 nuclease sensitivity experiments. The highly conserved 5' non-translated region of exon 1 is predicted to form a very stable hairpin structure which could regulate the Fli-1 expression at the post-transcriptional level. In Cas-Br-E-induced tumors, all the proviruses are found clustered within 35 nucleotides directly upstream the Fli-1 ATG start codon, thus deleting the hairpin structure from the transcript. Promoter activity was tested using the CAT reporter gene transfected in mouse and human erythroid cell lines. No promoter activity could be detected with various mouse Fli-1 promoter-CAT constructs containing 600 bp of the 5' flanking region, the complete exon 1, the 5' end of intron 1 and/or retroviral LTR sequence. Constructions of the human homologue containing nearly 1.5 kbp of Fli-1 5' flanking region was also inactive in transfected cells. These results suggest that multiple levels of regulation might control the Fli-1 expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679708     DOI: 10.1016/0167-4781(96)00060-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  A macrocyclic bis-acridine shifts the equilibrium from duplexes towards DNA hairpins.

Authors:  A Slama-Schwok; F Peronnet; E Hantz-Brachet; E Taillandier; M P Teulade-Fichou; J P Vigneron; M Best-Belpomme; J M Lehn
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

2.  Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.

Authors:  Anuratha Sakthianandeswaren; Joan M Curtis; Colleen Elso; Beena Kumar; Tracey M Baldwin; Sash Lopaticki; Lukasz Kedzierski; Gordon K Smyth; Simon J Foote; Emanuela Handman
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

3.  Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration.

Authors:  C Denicourt; E Edouard; E Rassart
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Negative and translation termination-dependent positive control of FLI-1 protein synthesis by conserved overlapping 5' upstream open reading frames in Fli-1 mRNA.

Authors:  S Sarrazin; J Starck; C Gonnet; A Doubeikovski; F Melet; F Morle
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

5.  Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.

Authors:  C Barat; E Rassart
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA.

Authors:  Robert D Bell; Xiaochun Long; Mingyan Lin; Jan H Bergmann; Vivek Nanda; Sarah L Cowan; Qian Zhou; Yu Han; David L Spector; Deyou Zheng; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-27       Impact factor: 8.311

7.  Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.

Authors:  J Starck; A Doubeikovski; S Sarrazin; C Gonnet; G Rao; A Skoultchi; J Godet; I Dusanter-Fourt; F Morle
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.

Authors:  Tamara K Nowling; Jennifer Dziadyk Fulton; Katherine Chike-Harris; Gary S Gilkeson
Journal:  Mol Immunol       Date:  2007-07-02       Impact factor: 4.407

9.  A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.

Authors:  Erin E Morris; May Y Amria; Emily Kistner-Griffin; John L Svenson; Diane L Kamen; Gary S Gilkeson; Tamara K Nowling
Journal:  Arthritis Res Ther       Date:  2010-11-18       Impact factor: 5.156

10.  Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis.

Authors:  Tangjingjun Liu; Lei Xia; Yao Yao; Chen Yan; Yanhua Fan; Babu Gajendran; Jue Yang; You-Jun Li; Juan Chen; Jorge Filmus; David E Spaner; Eldad Zacksenhaus; Xiaojiang Hao; Yaacov Ben-David
Journal:  Cell Death Dis       Date:  2019-02-11       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.